Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CsbD adhesin is the **tip adhesin protein of the CS17 fimbriae**, a class 5 fimbrial structure produced by enterotoxigenic Escherichia coli (ETEC). It mediates the specific binding of bacteria to the host intestinal epithelia, facilitating colonization and infection. Structurally, CsbD consists of two main domains: a lectin (adhesin) domain with a putative receptor-binding site and a pilin domain that anchors the adhesin to the fimbrial shaft, closely resembling the CfaE adhesin of CFA/I fimbriae[1][2]. Mutational analyses indicate that most adaptive changes cluster around the predicted ligand-binding pocket of the lectin domain, emphasizing its role in host interaction and immune evasion[1]. As a critical ETEC colonization factor, CsbD is explored as a potential **vaccine antigen**, with its structural integrity (including β-strands in the pilin domain) contributing to vaccine solubility, stability, and immunogenicity[2]. There are currently no approved drugs targeting CsbD directly, but it is considered a relevant anti-adhesion vaccine candidate.
Inhibition of adhesion of pathogens to host cells (theoretical for anti-adhesin agents or vaccines); not a direct drug target currently
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CsbD adhesin (CsbD).